Figure 1.
Treatment outcome of avelumab in relapsed or refractory ENKTL. (A) Waterfall plot of 21 patients. (B) Swimmer plot according to treatment duration and survival. (C) Representative images of patients showing complete and partial response and progression and the serial changes of EBV DNA titer in whole blood.